Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- MBX.TO
- Price
- 0.41
- Stock movement up
- +0.01 (1.23%)
- Company name
- Microbix Biosystems Inc.
- Exchange
- (TO ,
- Currency
- CAD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 55.16M
- Ent value
- 52.06M
- Price/Sales
- 2.36
- Price/Book
- 1.97
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 10.86
- Forward P/E
- -
- PEG
- -
- EPS growth
- -67.96%
- 1 year return
- 7.89%
- 3 year return
- -7.62%
- 5 year return
- 13.26%
- 10 year return
- -4.93%
Last updated: 2025-03-22
DIVIDENDS
MBX.TO does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 10.86 |
| Price to OCF | 25.95 |
| Price to FCF | 166.95 |
| Price to EBITDA | 61.00 |
| EV to EBITDA | 57.58 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2.36 |
| Price to Book | 1.97 |
| EV to Sales | 2.23 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 134.53M |
| EPS (TTM) | 0.04 |
| FCF per share (TTM) | 0.00 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 23.36M |
| Gross profit (TTM) | 13.37M |
| Operating income (TTM) | 5.42M |
| Net income (TTM) | 5.08M |
| EPS (TTM) | 0.04 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 57.21% |
| Operating margin (TTM) | 23.18% |
| Profit margin (TTM) | 21.73% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 12.81M |
| Net receivables | 4.09M |
| Total current assets | 23.92M |
| Goodwill | 0.00 |
| Intangible assets | 4.34M |
| Property, plant and equipment | 18.80M |
| Total assets | 37.73M |
| Accounts payable | 1.86M |
| Short/Current long term debt | 6.36M |
| Total current liabilities | 3.62M |
| Total liabilities | 9.71M |
| Shareholder's equity | 28.02M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 2.13M |
| Capital expenditures (TTM) | 1.80M |
| Free cash flow (TTM) | 330.38K |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 18.12% |
| Return on Assets | 13.46% |
| Return on Invested Capital | 15.03% |
| Cash Return on Invested Capital | 0.98% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.41 |
| Daily high | 0.41 |
| Daily low | 0.41 |
| Daily Volume | 6K |
| All-time high | 1.75 |
| 1y analyst estimate | 0.80 |
| Beta | 0.34 |
| EPS (TTM) | 0.04 |
| Dividend per share | - |
| Ex-div date | 2 Sep 1999 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| MBX.TO | S&P500 | |
| Current price drop from All-time high | -76.57% | -7.99% |
| Highest price drop | -92.86% | -56.47% |
| Date of highest drop | 4 Dec 2013 | 9 Mar 2009 |
| Avg drop from high | -66.70% | -11.07% |
| Avg time to new high | 203 days | 12 days |
| Max time to new high | 5962 days | 1805 days |
COMPANY DETAILS
Marketcap
55.16M
Marketcap category
Small-cap
Description
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Canada
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
In 2025, the Canadian stock market has experienced volatility and negative returns amid broader economic uncertainties, highlighting the importance of diversification in investment portfolios. Despite...
March 20, 2025
EPICC HPV Elimination Partnership being supplied PROCEEDxFLOQ QAPs to Support Test AccuracyMISSISSAUGA, Ontario and MELBOURNE, Australia, March 17, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (T...
March 17, 2025
Site Visit & Discussions with Premier Ford & MPP Deepak AnandMISSISSAUGA, Ontario, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a proudly Ontario Mad...
February 27, 2025
Using Shareholder-Approved Plan to Incentivize and RetainMISSISSAUGA, Ontario, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator...
February 26, 2025
Meetings with Growth-Oriented Investors, February 21 to 23, 2025MISSISSAUGA, Ontario, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences in...
February 19, 2025
Microbix Biosystems ( TSE:MBX ) First Quarter 2025 Results Key Financial Results Revenue: CA$6.04m (down 28% from 1Q...
February 15, 2025
Microbix Biosystems Inc (MBXBF) reports robust revenue growth and margin expansion, while navigating transient revenue impacts and strategic market entries.
February 15, 2025
Quarterly Revenues of $6.0 million and Net Income of $0.9 millionMISSISSAUGA, Ontario, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences i...
February 13, 2025
Results Release and Webinar Discussion on Morning of February 13, 2025MISSISSAUGA, Ontario, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life scien...
February 6, 2025
Further Capital to Assist with Increasing Capabilities, Capacity, and EfficiencyMISSISSAUGA, Ontario, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a ...
February 4, 2025
Next page